372 related articles for article (PubMed ID: 33383973)
21. Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma.
Yoon C; Cho SJ; Chang KK; Park DJ; Ryeom SW; Yoon SS
Mol Cancer Res; 2017 Aug; 15(8):1106-1116. PubMed ID: 28461325
[TBL] [Abstract][Full Text] [Related]
22. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition.
Lee J; Ha S; Jung CK; Lee HH
Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850
[TBL] [Abstract][Full Text] [Related]
23. TIPE1 suppresses invasion and migration through down-regulating Wnt/β-catenin pathway in gastric cancer.
Liu W; Chen Y; Xie H; Guo Y; Ren D; Li Y; Jing X; Li D; Wang X; Zhao M; Zhu T; Wang Z; Wei X; Gao F; Wang X; Liu S; Zhang Y; Yi F
J Cell Mol Med; 2018 Feb; 22(2):1103-1117. PubMed ID: 28994231
[TBL] [Abstract][Full Text] [Related]
24. Isoprenaline induces epithelial-mesenchymal transition in gastric cancer cells.
Lu YJ; Geng ZJ; Sun XY; Li YH; Fu XB; Zhao XY; Wei B
Mol Cell Biochem; 2015 Oct; 408(1-2):1-13. PubMed ID: 26253173
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9.
Chen KY; Chen CC; Chang YC; Chang MC
PLoS One; 2019; 14(7):e0219317. PubMed ID: 31310624
[TBL] [Abstract][Full Text] [Related]
26. GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail.
Zhao J; Yang C; Guo S; Wu Y
Int J Clin Exp Pathol; 2015; 8(9):10784-91. PubMed ID: 26617790
[TBL] [Abstract][Full Text] [Related]
27. Epithelial-mesenchymal transition in gastric cancer (Review).
Katoh M
Int J Oncol; 2005 Dec; 27(6):1677-83. PubMed ID: 16273224
[TBL] [Abstract][Full Text] [Related]
28. Tangeretin enhances radiosensitivity and inhibits the radiation-induced epithelial-mesenchymal transition of gastric cancer cells.
Zhang X; Zheng L; Sun Y; Wang T; Wang B
Oncol Rep; 2015 Jul; 34(1):302-10. PubMed ID: 25998143
[TBL] [Abstract][Full Text] [Related]
29. Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.
Navas T; Pfister TD; Colantonio S; Aziz A; Dieckman L; Saul RG; Kaczmarczyk J; Borgel S; Alcoser SY; Hollingshead MG; Lee YH; Bottaro DP; Hiltke T; Whiteley G; Takebe N; Kinders RJ; Parchment RE; Tomaszewski JE; Doroshow JH
PLoS One; 2018; 13(6):e0199361. PubMed ID: 29928062
[TBL] [Abstract][Full Text] [Related]
30. The expression level changes of microRNAs 200a/205 in the development of invasive properties in gastric cancer cells through epithelial-mesenchymal transition.
Mirzaei S; Baghaei K; Parivar K; Hashemi M; Asadzadeh Aghdaei H
Eur J Pharmacol; 2019 Aug; 857():172426. PubMed ID: 31150646
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus-mediated TIPE2 overexpression inhibits gastric cancer metastasis via reversal of epithelial-mesenchymal transition.
Yin H; Huang X; Tao M; Hu Q; Qiu J; Chen W; Wu J; Xie Y
Cancer Gene Ther; 2017 Apr; 24(4):180-188. PubMed ID: 28186089
[TBL] [Abstract][Full Text] [Related]
32. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
[TBL] [Abstract][Full Text] [Related]
33. miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer.
Wang S; Chen Y; Yu X; Lu Y; Wang H; Wu F; Teng L
Pathol Res Pract; 2019 Apr; 215(4):676-682. PubMed ID: 30635217
[TBL] [Abstract][Full Text] [Related]
34. Salinomycin reduces epithelial-mesenchymal transition-mediated multidrug resistance by modifying long noncoding RNA HOTTIP expression in gastric cancer cells.
Mao Z; Wu Y; Zhou J; Xing C
Anticancer Drugs; 2019 Oct; 30(9):892-899. PubMed ID: 30882398
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of the Epithelial-Mesenchymal Transition and Tumor Microenvironment in
Baj J; Korona-Głowniak I; Forma A; Maani A; Sitarz E; Rahnama-Hezavah M; Radzikowska E; Portincasa P
Cells; 2020 Apr; 9(4):. PubMed ID: 32340207
[No Abstract] [Full Text] [Related]
36. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).
Cho ES; Kang HE; Kim NH; Yook JI
Arch Pharm Res; 2019 Jan; 42(1):14-24. PubMed ID: 30649699
[TBL] [Abstract][Full Text] [Related]
37. TRPC1/3/6 inhibition attenuates the TGF-β1-induced epithelial-mesenchymal transition in gastric cancer via the Ras/Raf1/ERK signaling pathway.
Ge P; Wei L; Zhang M; Hu B; Wang K; Li Y; Liu S; Wang J; Li Y
Cell Biol Int; 2018 Aug; 42(8):975-984. PubMed ID: 29570903
[TBL] [Abstract][Full Text] [Related]
38. Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells.
Choupani J; Mansoori Derakhshan S; Bayat S; Alivand MR; Shekari Khaniani M
J Cell Physiol; 2018 Jun; 233(6):4443-4457. PubMed ID: 29194618
[TBL] [Abstract][Full Text] [Related]
39. The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated β-catenin in gastric cancer.
Zhao W; Jia L; Kuai X; Tang Q; Huang X; Yang T; Qiu Z; Zhu J; Huang J; Huang W; Feng Z
Cancer Med; 2019 Mar; 8(3):1135-1147. PubMed ID: 30632714
[TBL] [Abstract][Full Text] [Related]
40. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]